Betamethasone Valerate is Used for treating skin diseases with corticosteroid-containing pharmaceutical compositions. It was first introduced by Schering Corp Sub Schering Plough Corp in its drug Valisone on Approved Prior to Jan 1, 1982. Other drugs containing Betamethasone Valerate are Betamethasone Valerate, Beta-Val, Betatrex, Luxiq, Betaderm. 17 different companies have introduced drugs containing Betamethasone Valerate.

Betamethasone Valerate Patents

Given below is the list of patents protecting Betamethasone Valerate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Luxiq	US7078058	Corticosteroid-containing pharmaceutical composition	May 24, 2017 (Expired)	Pharmobedient
Luxiq	US6126920	Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition	Mar 01, 2016 (Expired)	Pharmobedient

Add above patents to watchlist

Betamethasone Valerate's Family Patents

Full family tree

Betamethasone Valerate Generic API Manufacturers

Several generic applications have been filed for Betamethasone Valerate. The first generic version for Betamethasone Valerate was by Actavis Mid Atlantic Llc and was approved on Oct 10, 1984. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Aug 22, 2024.

Given below is the list of companies who have filed for Betamethasone Valerate generic, along with the locations of their manufacturing plants worldwide.